85 related articles for article (PubMed ID: 23758202)
1. Evaluation of macroprolactinemia in 259 women under investigation for polycystic ovary syndrome.
Hayashida SA; Marcondes JA; Soares JM; Rocha MP; Barcellos CR; Kobayashi NK; Baracat EC; Maciel GA
Clin Endocrinol (Oxf); 2014 Apr; 80(4):616-8. PubMed ID: 23758202
[No Abstract] [Full Text] [Related]
2. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
[TBL] [Abstract][Full Text] [Related]
3. [Physiopathological link between polycystic ovary syndrome and hyperprolactinemia: myth or reality?].
Robin G; Catteau-Jonard S; Young J; Dewailly D
Gynecol Obstet Fertil; 2011 Mar; 39(3):141-5. PubMed ID: 21388855
[TBL] [Abstract][Full Text] [Related]
4. Macroprolactinemia in women presenting with hyperandrogenic symptoms: Implications for the management of polycystic ovary syndrome.
Escobar-Morreale HF
Fertil Steril; 2004 Dec; 82(6):1697-9. PubMed ID: 15589886
[TBL] [Abstract][Full Text] [Related]
5. Polycystic ovary syndrome and hyperprolactinemia are distinct entities.
Filho RB; Domingues L; Naves L; Ferraz E; Alves A; Casulari LA
Gynecol Endocrinol; 2007 May; 23(5):267-72. PubMed ID: 17558684
[TBL] [Abstract][Full Text] [Related]
6. Characterization of unilateral polycystic ovary compared with polycystic ovary syndrome.
Yao LQ; Kuang JQ; Feng YJ; Yang DZ; Li L; Xu CJ
Fertil Steril; 2006 Mar; 85(3):805-8. PubMed ID: 16500371
[TBL] [Abstract][Full Text] [Related]
7. High-sensitivity C-reactive protein is a marker of obesity and not of polycystic ovary syndrome per se.
Gowri V; Rizvi SG; Squib S; Al Futaisi A
Fertil Steril; 2010 Dec; 94(7):2832-4. PubMed ID: 20561613
[TBL] [Abstract][Full Text] [Related]
8. Polycystic ovary syndrome or hyperprolactinaemia: a study of mild hyperprolactinaemia.
Su HW; Chen CM; Chou SY; Liang SJ; Hsu CS; Hsu MI
Gynecol Endocrinol; 2011 Jan; 27(1):55-62. PubMed ID: 20504100
[TBL] [Abstract][Full Text] [Related]
9. Prolactin response to clomiphene citrate is different in hyperprolactinemic polycystic ovary syndrome and idiopathic hyperprolactinemia.
Lewinthal D; Corenblum B; Taylor PJ
Int J Fertil; 1987; 32(3):185-7, 191. PubMed ID: 2885281
[No Abstract] [Full Text] [Related]
10. Re: Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women.
Verit FF
Fertil Steril; 2010 Apr; 93(6):e27; author reply e28. PubMed ID: 20171617
[No Abstract] [Full Text] [Related]
11. Polycystic ovary syndrome and the metabolic syndrome.
Weerakiet S
J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S189-93. PubMed ID: 21213522
[TBL] [Abstract][Full Text] [Related]
12. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance and overweight-obese women with polycystic ovary syndrome.
Bhattacharya SM
Gynecol Endocrinol; 2010 May; 26(5):344-7. PubMed ID: 19903118
[TBL] [Abstract][Full Text] [Related]
14. Hyperprolactinemia after laparoscopic ovarian drilling: an unknown phenomenon.
Parsanezhad ME; Alborzi S; Zolghadri J; Parsa-Nezhad M; Keshavarzi G; Omrani GR; Schmidt EH
Reprod Biol Endocrinol; 2005 Aug; 3():31. PubMed ID: 16083511
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic difficulties of polycystic ovarian syndrome in adolescent girls].
Ságodi L; Barkai L
Orv Hetil; 2013 Jan; 154(4):136-42. PubMed ID: 23335723
[TBL] [Abstract][Full Text] [Related]
16. Ovulatory disorders in women with polycystic ovary syndrome.
Franks S; Adams J; Mason H; Polson D
Clin Obstet Gynaecol; 1985 Sep; 12(3):605-32. PubMed ID: 3933879
[TBL] [Abstract][Full Text] [Related]
17. Plasma GDF-15 levels and their association with hormonal and metabolic status in women with polycystic ovary syndrome aged 25-35.
Berberoglu Z; Aktas A; Fidan Y; Canan Yazici A; Aral Y
Minerva Endocrinol; 2014 Jun; 39(2):89-97. PubMed ID: 24736483
[TBL] [Abstract][Full Text] [Related]
18. [Effect of hyperprolactinemia upon clinical symptoms of patients with polycystic ovary syndrome].
Wang Y; Hu ZP; Li MZ; Li R; Wang LN; Chen XN; Yang CS; Qiao J
Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(37):2599-603. PubMed ID: 20137674
[TBL] [Abstract][Full Text] [Related]
19. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.
Stepto NK; Cassar S; Joham AE; Hutchison SK; Harrison CL; Goldstein RF; Teede HJ
Hum Reprod; 2013 Mar; 28(3):777-84. PubMed ID: 23315061
[TBL] [Abstract][Full Text] [Related]
20. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
